Citations

Showing 10 of 108152 citations.

Topical Tranexamic Acid Safely Reduces Seroma and Time to Drain Removal Following Implant-Based Breast Reconstruction
Weissler, Jason M., Banuelos, Joseph, Alsayed, Ahmed , Tran, Nho V. , Martinez‐Jorge, Jorys, Manrique, Oscar J. , Nguyen, Minh-Doan T. , Harless, Christin A.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 7, 2021 | Volume: 8 | Issue: 9S | Pages: 9-10

10.1097/01.gox.0000720320.20525.02 Get It

Outcome Analysis of Free Flaps in Patients With Collagen Vascular Disorders: 10-year Single Institution Review
Singh, Kuldeep , Carlsen, Brian T. , Moran, Steven L. , Vijayasekaran, Aparna , Yan, María

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 7, 2021 | Volume: 8 | Issue: 9S | Pages: 83-84

10.1097/01.gox.0000720728.23377.ca Get It

Alternatives to Acellular Dermal Matrix in Breast Reconstruction: Outcomes from Dermal Autograft Assisted Tissue Expander Breast Reconstruction in 104 Consecutive Patients
Rinker, Brian

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 7, 2021 | Volume: 8 | Issue: 9S | Pages: 11-12

10.1097/01.gox.0000720332.45888.3d Get It

Recurrent Hypoglycemia Due to a Massive Abdominal Tumor in a Nonagenarian: A Case Report and Review of the Literature
Reizun, Catherine E., Sorrells, William S., Grossman, Robert , Sorrells, W Sheaffer, Grossman, Robert A.

Mayo Clinic

American Journal of Case Reports | May 7, 2021 | Volume: 22 | Issue: No issue available | Pages: No page available

10.12659/ajcr.930727 | PMID 34088888 Get It

An Analysis of Procedural Medicare Reimbursement Rates in Craniofacial Plastic Surgery: 2000–2019
Thornburg, Danielle A. , Chow, Nathan , Haglin, Jack M. , Chow, Nathan A , Gupta, Nikita , Singh, Davinder

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 7, 2021 | Volume: 8 | Issue: 9S | Pages: 33-33

10.1097/01.gox.0000720448.94083.2f Get It

Chylothorax as a complication of Waldenström macroglobulinaemia with a patient’s perspective
Gary, Phillip , Gianniosis, Margarita, Ryu, Jay H. , Ryu, Jay, Ryu, Jay H , Gary, Phillip J , Flynn, Samantha

Mayo Clinic

BMJ Case Reports | May 7, 2021 | Volume: 14 | Issue: 5 | Pages: e241707

10.1136/bcr-2021-241707 | PMID 33962927 Get It

Chylothorax has rarely been reported as a pleuropulmonary complication of Waldenström macroglobulinaemia (WM). In general, when a unilateral effusion is discovered particularly in patients with a history of cancer or active malignancy, a broad differential including chylothorax needs to be considered. We present the case of a 50-year-old woman found to have chylothorax secondary to progression of WM as confirmed by cytology and presence of MYD88 L265P mutation in the pleural fluid specimen and subsequent resolution with chemotherapy. This review centres particularly on non-traumatic causes of chylothorax with a focus on WM and includes a unique patient perspective.
Neuroinflammation in Alzheimer’s Disease
Onyango, Isaac G. , Jáuregui, Gretsen Velezmoro , Čarná, Mária , Bennett, James P. , Stokin, Gorazd B. , Stokin, Gorazd

Mayo Clinic

Biomedicines | May 7, 2021 | Volume: 9 | Issue: 5 | Pages: 524

10.3390/biomedicines9050524 | PMID 34067173 Get It

Alzheimer’s disease (AD) is a neurodegenerative disease associated with human aging. Ten percent of individuals over 65 years have AD and its prevalence continues to rise with increasing age. There are currently no effective disease modifying treatments for AD, resulting in increasingly large socioeconomic and personal costs. Increasing age is associated with an increase in low-grade chronic inflammation (inflammaging) that may contribute to the neurodegenerative process in AD. Although the exact mechanisms remain unclear, aberrant elevation of reactive oxygen and nitrogen species (RONS) levels from several endogenous and exogenous processes in the brain may not only affect cell signaling, but also trigger cellular senescence, inflammation, and pyroptosis. Moreover, a compromised immune privilege of the brain that allows the infiltration of peripheral immune cells and infectious agents may play a role. Additionally, meta-inflammation as well as gut microbiota dysbiosis may drive the neuroinflammatory process. Considering that inflammatory/immune pathways are dysregulated in parallel with cognitive dysfunction in AD, elucidating the relationship between the central nervous system and the immune system may facilitate the development of a safe and effective therapy for AD. We discuss some current ideas on processes in inflammaging that appear to drive the neurodegenerative process in AD and summarize details on a few immunomodulatory strategies being developed to selectively target the detrimental aspects of neuroinflammation without affecting defense mechanisms against pathogens and tissue damage.
Temporal Incidence and Predictors of High‐Grade Atrioventricular Block After Transcatheter Aortic Valve Replacement
El‐Sabawi, Bassim , Welle, Garrett A. , Cha, Yong‐Mei , Espinosa, Raúl E. , Gulati, Rajiv , Sandhu, Gurpreet S. , Greason, Kevin L. , Friedman, Paul A. , Munger, Thomas M. , Rihal, Charanjit S. , Eleid, Mackram F. , Welle, Garrett A , Crestanello, Juan A. , Rihal, Charanjit S.

Mayo Clinic

Journal of the American Heart Association | May 7, 2021 | Volume: 10 | Issue: 10 | Pages: No page available

10.1161/jaha.120.020033 | PMID 33960210 Get It

Background The temporal incidence of high‐grade atrioventricular block (HAVB) after transcatheter aortic valve replacement (TAVR) is uncertain. As a result, periprocedural monitoring and pacing strategies remain controversial. This study aimed to describe the temporal incidence of initial episode of HAVB stratified by pre‐ and post‐TAVR conduction and identify predictors of delayed events. Methods and Results Consecutive patients undergoing TAVR at a single center between February 2012 and June 2019 were retrospectively assessed for HAVB within 30 days. Patients with prior aortic valve replacement, permanent pacemaker (PPM), or conversion to surgical replacement were excluded. Multivariable logistic regression was performed to assess predictors of delayed HAVB (initial event >24 hours post‐TAVR). A total of 953 patients were included in this study. HAVB occurred in 153 (16.1%). After exclusion of those with prophylactic PPM placed post‐TAVR, the incidence of delayed HAVB was 33/882 (3.7%). Variables independently associated with delayed HAVB included baseline first‐degree atrioventricular block or right bundle‐branch block, self‐expanding valve, and new left bundle‐branch block. Forty patients had intraprocedural transient HAVB, including 16 who developed HAVB recurrence and 6 who had PPM implantation without recurrence. PPM was placed for HAVB in 130 (13.6%) (self‐expanding valve, 23.7% versus balloon‐expandable valve, 11.9%; P <0.001). Eight (0.8%) patients died by 30 days, including 1 unexplained without PPM present. Conclusions Delayed HAVB occurs with higher frequency in patients with baseline first‐degree atrioventricular block or right bundle‐branch block, new left bundle‐branch block, and self‐expanding valve. These findings provide insight into optimal monitoring and pacing strategies based on periprocedural ECG findings.
Detection of a mosaic CDKL5 deletion and inversion by optical genome mapping ends an exhaustive diagnostic odyssey
Cope, Heidi , Barseghyan, Hayk , Bhattacharya, Surajit, Fu, Yulong , Hoppman, Nicole L., Marcou, Cherisse A. , Walley, Nicole, Rehder, Catherine , Deak, Kristen , Alkelai, Anna , Network, Undiagnosed Diseases, Shashi, Vandana , Oglesbee, Devin , Jarvik, Gail P. , McCauley, Jacob L. , Nelson, Stanley F. , Azamian, Mahshid S. , Martínez-Agosto, Julián A. , Chang, Ta Chen , Blue, Elizabeth , Douine, Emilie D. , Woods, Jeremy D. , Baldridge, Dustin , Hoppman, Nicole, Marcou, Cherisse, Oglesbee, Devin , Jarvik, Gail P , Baldridge, Dustin , McCauley, Jacob L , Bhattacharya, Surajit , Walley, Nicole, Network, Undiagnosed Diseases, Vilain, Eric J. N.

Mayo Clinic

Molecular Genetics & Genomic Medicine | May 7, 2021 | Volume: 9 | Issue: 7 | Pages: No page available

10.1002/mgg3.1665 | PMID 33955715 Get It

ABSTRACTBackgroundCurrently available structural variant (SV) detection methods do not span the complete spectrum of disease‐causing SVs. Optical genome mapping (OGM), an emerging technology with the potential to resolve diagnostic dilemmas, was performed to investigate clinically‐relevant SVs in a 4‐year‐old male with an epileptic encephalopathy of undiagnosed molecular origin.MethodsOGM was utilized to image long, megabase‐size DNA molecules, fluorescently labeled at specific sequence motifs throughout the genome with high sensitivity for detection of SVs greater than 500 bp in size. OGM results were confirmed in a CLIA‐certified laboratory via mate‐pair sequencing.ResultsOGM identified a mosaic, de novo 90 kb deletion and inversion on the X chromosome disrupting the CDKL5 gene. Detection of the mosaic deletion, which had been previously undetected by chromosomal microarray, an infantile epilepsy panel including exon‐level microarray for CDKL5, exome sequencing as well as genome sequencing, resulted in a diagnosis of X‐linked dominant early infantile epileptic encephalopathy‐2.ConclusionOGM affords an effective technology for the detection of SVs, especially those that are mosaic, since these remain difficult to detect with current NGS technologies and with conventional chromosomal microarrays. Further research in undiagnosed populations with OGM is warranted.
Vascular Surgery and Neurosurgery
Lanzino, Giuseppe , Lanzino, Giuseppe , Halliday, Alison W.

Mayo Clinic

Stroke | May 7, 2021 | Volume: 52 | Issue: 6 | Pages: 2174-2176

10.1161/strokeaha.121.033293 | PMID 33957775 Get It